Multivitamin Supplement Use and Risk of Breast Cancer: A Meta-Analysis

Chi Mei Medical Center, Tainan, Taiwan.
Annals of Pharmacotherapy (Impact Factor: 2.06). 04/2011; 45(4):476-84. DOI: 10.1345/aph.1P445
Source: PubMed


The association between consumption of multivitamins and breast cancer is inconsistent in epidemiologic studies.
To perform a meta-analysis of cohort and case-control studies to evaluate multivitamin intake and its relationship with breast cancer risk.
The published literature was systematically searched and reviewed using MEDLINE (1950 through July 2010), EMBASE (1980 through July 2010), and the Cochrane Central Register of Controlled Trials (The Cochrane Library 2010 issue 1). Studies that included specific risk estimates were pooled using a random-effects model. The bias and quality of these studies were assessed with REVMAN statistical software (version 5.0) and the GRADE method of the Cochrane Collaboration.
Eight of 27 studies that included 355,080 subjects were available for analysis. The total duration of multivitamin use in these trials ranged from 3 to 10 years. The frequency of current use in these studies ranged from 2 to 6 times/week. In analyses by duration of use 10 years or longer or 3 years or longer and by frequency 7 or more times/week that were reported in these studies, multivitamin use was not significantly associated with the risk of breast cancer. Only 1 recent Swedish cohort study concluded that multivitamin use is associated with an increased risk of breast cancer. The results of a meta-analysis that pooled data from 5 cohort studies and 3 case-control studies indicated that the overall multivariable relative risk and odds ratio were 0.10 (95% CI 0.60 to 1.63; p = 0.98) and 1.00 (95% CI 0.51 to 1.00; p = 1.00), respectively. The association was not statistically significant.
Multivitamin use is likely not associated with a significant increased or decreased risk of breast cancer, but these results highlight the need for more case-control studies or randomized controlled clinical trials to further examine this relationship.

Full-text preview

Available from:
  • Source
    • "case–control studies: odds ratio [OR]: 1.00; 95% CI: 0.51–1.97) [61]. Furthermore, the Women’s Health Initiative, a large observational study, reported that MVM supplement use was not associated with an increase in risk of breast, colorectal, endometrial, ovarian, kidney, bladder, stomach, or lung cancer in postmenopausal women [62]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A balanced and varied diet is the best source of essential vitamins and minerals; however, nutrient deficiencies occur, including in populations with bountiful food supplies and the means to procure nutrient-rich foods. For example, the typical American diet bears little resemblance to what experts recommend for fruit, vegetables, and whole grains, which serve as important sources of an array of vitamins and minerals. With time, deficiencies in one or more micronutrients may lead to serious health issues. A common reason people take multivitamin and mineral (MVM) supplements is to maintain or improve health, but research examining the effectiveness of MVMs in the prevention of certain chronic conditions is ongoing. In addition to the utility of MVMs for filling in relatively small but critical nutritional gaps, which may help prevent conditions such as anemia, neural tube defects, and osteoporosis, some evidence supports possible benefits of MVM supplementation with regard to cancer prevention (particularly in men) and prevention or delay of cataract, as well as some aspects of cognitive performance. Unlike some single-vitamin supplements, MVM supplements are generally well tolerated and do not appear to increase the risk of mortality, cerebrovascular disease, or heart failure. The potential benefits of MVM supplements likely outweigh any risk in the general population and may be particularly beneficial for older people.
    Nutrition Journal 07/2014; 13(1):72. DOI:10.1186/1475-2891-13-72 · 2.60 Impact Factor

  • Journal of Obstetric Gynecologic & Neonatal Nursing 07/2012; 41(1):103-11. DOI:10.1111/j.1552-6909.2011.01327.x · 1.02 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gemäß den Angaben der Deutschen Gesellschaft für Ernährung (DGE) und des Bundesinstitutes für Risikobewertung (BfR) kann die tägliche Mikronährstoffversorgung bei Gesunden auch unter den heutigen Bedingungen durch eine ausgewogene Ernährung gedeckt werden. Lediglich in Bevölkerungsgruppen mit erhöhtem Bedarf kann die zusätzliche Aufnahme bestimmter Stoffe, wie Jod, Eisen, Kalzium, Folsäure oder VitaminD, sinnvoll sein. Dennoch verwendet in Deutschland etwa jede dritte Frau und jeder vierte Mann regelmäßig Nahrungsergänzungsmittel, in der Regel ohne Rücksprache mit einem Arzt. Das birgt die Gefahr inadäquater Dosierungen und möglicher Wechselwirkungen mit Medikamenten. Anders als bei Arzneimitteln muss für die Vermarktung die Wirksamkeit von Nahrungsergänzungsmitteln nicht in klinischen Studien belegt worden sein. Die Datenlage bezüglich pauschaler Vitamin- und Mineralstoffsupplementierungen zur Prävention von Herz-Kreislauf-Erkrankungen und Krebs ist kontrovers, der Grat zwischen Nutzen und Risiko schmal. According to the German Nutrition Society (DGE) and the Federal Institute for Risk Assessment (BfR) in healthy subjects the daily allowance of micronutrients can be covered by adequate nutrition even under the present conditions. Solely in demographic groups with increased requirements, the supplementary intake of certain nutrients such as iron, iodine, and calcium as well as folate and vitamin D may be considered. Nevertheless, in Germany every third woman and every fourth man use dietary supplements on a regular basis, commonly without consulting their physician, which carries the risk of inadequate dosages and possible interactions with drugs. In contrast to pharmaceuticals there is no need to demonstrate their efficacy in clinical trials for marketing dietary supplements. Data as to the general supplementation of vitamins and minerals to prevent cardiovascular events and cancer are controversial, and their use is a tight balancing act between risk and benefit. SchlüsselwörterHomozystein–Vitamine–Mineralstoffe–Krebs–Herz-Kreislauf-Erkrankungen KeywordsHomocysteine–Vitamins–Minerals–Cancer –Cardiovascular disease
    Der Gynäkologe 03/2012; 44(8):659-666. DOI:10.1007/s00129-011-2791-x
Show more